Congrong Runtong Oral Liquid in the Treatment of Functional Constipation (Yang-deficiency Type) - Trial NCT05803161
Access comprehensive clinical trial information for NCT05803161 through Pure Global AI's free database. This Phase 2 trial is sponsored by Beijing Hospital of Traditional Chinese Medicine and is currently Not yet recruiting. The study focuses on Functional Constipation. Target enrollment is 180 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Beijing Hospital of Traditional Chinese Medicine
Timeline & Enrollment
Phase 2
Apr 01, 2023
Jun 30, 2025
Primary Outcome
Complete Spontaneous Bowel Movement (CSBM) response rate within 8 weeks of treatment
Summary
Using a placebo as a control, this study aims to preliminarily evaluate the clinical efficacy
 of Congrong Runtong oral liquid for the treatment of functional constipation (Yang-deficiency
 type), explore the optimal dosage of Congrong Runtong oral liquid for functional constipation
 (Yang-deficiency type) to provide a basis for dosage selection in Phase III clinical trials,
 and observe the safety of clinical use of Congrong Runtong oral liquid.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05803161
Non-Device Trial